These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13531429)

  • 1. [The role of pH in the effect of two ethyleneimine quinones (Bayer E 39 and Bayer A 139) on nucleic acids].
    SCHOLTISSEK C
    Z Krebsforsch; 1957; 62(2):109-11. PubMed ID: 13531429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polarographic analysis of cytostatic quinone derivatives. II. The redox system 2,5-bis-(ethyleneimine)-3,6-bis-(n-porpoxy)-benzoquinone-(1,4)].
    BERG H; KONIG KH
    Z Krebsforsch; 1958; 62(5):495-500. PubMed ID: 13625829
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the action of 2, 5-bis(2-methoxyethoxy)-3, 6-bis-ethylenimino-1, 4-benzoquinone (Bayer A 139) on the glycolysis of ascites tumor cells].
    SCRIBA P; SCHNEIDER S; HOLZER H
    Z Krebsforsch; 1960; 63():547-57. PubMed ID: 13749428
    [No Abstract]   [Full Text] [Related]  

  • 4. Liquid chromatography determination of an antineoplastic aziridinylbenzoquinone in human and murine serum.
    Allen BA; Newman RA; Griffin JP; McCormack JJ
    J Chromatogr; 1981 Jan; 222(1):146-51. PubMed ID: 7217323
    [No Abstract]   [Full Text] [Related]  

  • 5. [E 39, a new antitumoral substance of the ethyleneimine-qulnone group; properties and clinical indications].
    PESTEL M
    Presse Med (1893); 1956 Sep; 64(64):1474-5. PubMed ID: 13379258
    [No Abstract]   [Full Text] [Related]  

  • 6. [PHYTOBIOLOGICAL EVALUATION OF THE CYTOSTATIC EFFECT OF ETHYLENEIMINO-1,4-BENZOQUINONES USED IN CANCER CHEMOTHERAPY].
    CONSTANTINESCU DG; RETEZEANU M; OTELEANU R; CONSTANTINESCU M
    Pharmazie; 1963 Oct; 18():699-703. PubMed ID: 14204170
    [No Abstract]   [Full Text] [Related]  

  • 7. A rapid and sensitive micro-assay to determine the capacity of quinones to undergo redox cycling.
    Hart LA; van der Wal NA; Koster AS; Labadie RP
    Toxicol Lett; 1989 Aug; 48(2):151-7. PubMed ID: 2772921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary report on the treatment of plasmocytoma with an ethyleneimino-quinone preparation (E 39 Bayer)].
    HEILMANN D
    Dtsch Med J; 1957 Nov; 8(11):565-9. PubMed ID: 13490130
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
    Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
    Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
    [No Abstract]   [Full Text] [Related]  

  • 10. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
    Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
    Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action in vitro of 2-5-bis-methoxy-ethoxy-3-6-bisethyleneimino-benzoquinone (Bayer E 39) on Trypanosoma cruzi].
    PIULATS E; ABITBOL H; PODESTA D; BORIS E; SCHEER A
    Dia Med; 1963 Apr; 35():382. PubMed ID: 13943875
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
    Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
    J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic trials with hamster mesothelioma 10-24: responses to azacitidine, aziridinylbenzoquinone, cisplatin, and PCNU.
    Holiat SM; Smith WE; Hubert DD; Davis S
    Cancer Treat Rep; 1981; 65(11-12):1113-5. PubMed ID: 6170430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE TREATMENT OF BRONCHOGENIC CARCINOMA BY CHEMICAL AGENTS.
    MADEJCZYK A; ZBORZIL J; ZELECHOWSKA A; ZULAWSKI M
    Acta Unio Int Contra Cancrum; 1963; 19():1368-70. PubMed ID: 14103950
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
    Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation kinetics and mechanism of RH1, a new anti-tumor agent: a technical note.
    Jain N; Machatha SG; Tabibi SE; Yalkowsky SH
    AAPS PharmSciTech; 2007 Mar; 8(1):16. PubMed ID: 17408216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytostatic treatment of malignant tumors with alcoxyethyleneimino-benzoquinone; Bayer E 39].
    SCHWERMER B; SCHREIBER HW
    Dtsch Med Wochenschr; 1958 Feb; 83(9):331-8. PubMed ID: 13512076
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
    Da Silva VF; Raaphorst GP; Goyal R; Feeley M
    J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
    Kamen BA; Holcenberg JS; Siegel SE
    Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.